Literature DB >> 8042279

Effect of chronic feline immunodeficiency virus infection on experimental feline calicivirus-induced disease.

G H Reubel1, J W George, J Higgins, N C Pedersen.   

Abstract

Acute feline calicivirus (FCV) infection caused a more severe disease in chronically feline immunodeficiency virus (FIV) infected than in non-FIV infected cats. FIV infected cats shed significantly higher amounts of FCV through their saliva after FCV challenge than the non-FIV infected cats. However, there was no difference in the duration of FCV shedding. None of the cats exposed to FCV developed chronic FCV carriage. Both groups of cats mounted similar titers of neutralizing antibodies to FCV. Although FIV infected cats started out with significantly lower total lymphocyte and neutrophil numbers than the non-FIV infected cats, the transient lymphopenia and neutrophilia attributable to the FCV infection was of similar intensity in both groups of animals. There was no evidence that the underlying FIV-related disease or viremia was influenced by acute FCV infection. Acute FCV infection did not significantly alter the CD4+/CD8+ T lymphocyte ratio in FIV infected compared to non-FIV infected cats. The ongoing humoral IgG response to FIV was not affected by the FCV infection. There was no significant change in the proportion of FIV infected peripheral blood mononuclear cells during 8 subsequent weeks after FCV challenge as determined by polymerase chain reaction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8042279     DOI: 10.1016/0378-1135(94)90169-4

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  12 in total

1.  Immunopathologic changes in the thymus during the acute stage of experimentally induced feline immunodeficiency virus infection in juvenile cats.

Authors:  J C Woo; G A Dean; N C Pedersen; P F Moore
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Proviral burden and infection kinetics of feline immunodeficiency virus in lymphocyte subsets of blood and lymph node.

Authors:  G A Dean; G H Reubel; P F Moore; N C Pedersen
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Two related strains of feline infectious peritonitis virus isolated from immunocompromised cats infected with a feline enteric coronavirus.

Authors:  A M Poland; H Vennema; J E Foley; N C Pedersen
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

4.  Contrasting clinical outcomes in two cohorts of cats naturally infected with feline immunodeficiency virus (FIV).

Authors:  Paweł M Bęczkowski; Annette Litster; Tsang Long Lin; Dominic J Mellor; Brian J Willett; Margaret J Hosie
Journal:  Vet Microbiol       Date:  2015-01-03       Impact factor: 3.293

Review 5.  Therapeutic Management of Feline Chronic Gingivostomatitis: A Systematic Review of the Literature.

Authors:  Jenna N Winer; Boaz Arzi; Frank J M Verstraete
Journal:  Front Vet Sci       Date:  2016-07-18

Review 6.  An Update on Feline Chronic Gingivostomatitis.

Authors:  Da Bin Lee; Frank J M Verstraete; Boaz Arzi
Journal:  Vet Clin North Am Small Anim Pract       Date:  2020-04-18       Impact factor: 2.093

Review 7.  Clinical aspects of feline immunodeficiency and feline leukemia virus infection.

Authors:  Katrin Hartmann
Journal:  Vet Immunol Immunopathol       Date:  2011-07-21       Impact factor: 2.046

Review 8.  Clinical aspects of feline retroviruses: a review.

Authors:  Katrin Hartmann
Journal:  Viruses       Date:  2012-10-31       Impact factor: 5.048

Review 9.  When domestic cat (Felis silvestris catus) population structures interact with their viruses.

Authors:  Dominique Pontier; David Fouchet; Narges Bahi-Jaber; Hervé Poulet; Micheline Guiserix; Eugenia Natoli; Frank Sauvage
Journal:  C R Biol       Date:  2008-11-28       Impact factor: 1.583

10.  A pilot study to evaluate the serum Alpha-1 acid glycoprotein response in cats suffering from feline chronic gingivostomatitis.

Authors:  Lisa A Mestrinho; Rita Rosa; Patrícia Ramalho; Vasco Branco; Leonor Iglésias; Hugo Pissarra; Ana Duarte; Maria Niza
Journal:  BMC Vet Res       Date:  2020-10-15       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.